**EXHIBIT
        31.2**
 
 **CERTIFICATION  OF
        CHIEF FINANCIAL  OFFICER  PURSUANT TO
        SECURITIES  EXCHANGE ACT**
 **RULES
        13A-14 AND 15D-14 AS ADOPTED PURSUANT TO SECTION 302 OF THE**
 **SARBANES-OXLEY** **ACT
        OF 2002**
 
 In
        connection  with the Form 10-QSB of Biomoda,  Inc. for the
        quarter ended June  30,  2007
        (the  "quarterly  report")  as
        filed  with the  Securities  and Exchange  Commission
        on the date hereof, I John J Cousins as President and Chief Financial
        Officer of the Company, certify that:
 
 1.
        I have
        reviewed this  quarterly  report on Form 10-QSB of
        Biomoda,  Inc. (the "registrant");
 
 2.
        Based
        on
        my  knowledge,  this  quarterly  report  does
        not contain any untrue statement
        of a material fact or omit to state a material fact  necessary to make the
        statements made, in light of the  circumstances  under which
        such statements were
        made,  not  misleading  with respect to the period
        covered by his quarterly report;
 
 3.  Based  on  my  knowledge,  the  financial  statements  and  other  financial information  included
        in this quarterly  report,  fairly present in all material respects
        the financial  condition,  results of
        operations  and cash flows of the
 registrant
        as of, and for the periods presented in this quarterly report;
 4.
        I am
        responsible for  establishing  and
        maintaining  disclosure  controls and procedures  (as
        defined in Exchange Act
        rules  13a-15(e)  and  15d-15(e) for the registrant
        and have:
 
 a.  Designed  such  disclosure  controls
        and  procedures or caused such disclosure   controls  and   procedures   to  be  designed  under  our supervision,  to  ensure  that  material  information  relating  to
        the
 registrant,  including
        its consolidated  subsidiary is made known to us by
        others  within  those  entities,  particularly  during
        the period in which
        this quarterly report is being prepared;
 
 b.
        Evaluated the effectiveness of the registrant's  disclosure
        controls and
        procedures and presented in this quarterly  report
        our  conclusions about
        the effectiveness of the disclosure controls and procedures as of
 the
        end of the period covered by this report based on
        such  evaluation; and
 
 c.  Disclosed  in
        this report any change in
        the  registrant's  internal control
        over financial  reporting that occurred during the
        registrant's most
        recent fiscal quarter (the  registrant's  fourth fiscal
        quarter in the
        case of an  annual  report)  that
        has  materially  affected,  or is reasonably  likely
        to  materially  affect,  the  registrant's  internal control
        over financial reporting;
 
 5.
        I
        have  disclosed,  based on our most
        recent  evaluation of internal  control over
        financial  reporting,  to
        the  registrant's  auditors and the  registrant's board
        of
        directors (or persons performing the equivalent functions);
 
 a.
        All significant  deficiencies in the design or operation of
        internal controls  which  could  adversely  affect
        the  registrant's  ability to record,
        process, summarize and report financial information; and
 
 b.
        Any fraud,  whether or
        not  material,  that  involves  management
        or other  employees  who  have
        a  significant  role  in  the  registrant's internal
        control over financial reporting.


**Biomoda, Inc.**August
                  20,
                  2007
              By:
              /s/ John
                J
                CousinsJohn
                J CousinsPresident
&
                Chief Financial Officer